Synthesis, Biochemical Characterization, and in-Silico Investigations of Acyl-3-(Ciprofloxacinyl) Thioureas as Inhibitors of Carbonic Anhydrase-II

References

• Y. J. Zheng, and K. M. Merz, Jr, “Mechanism of the Human Carbonic Anhydrase II-Catalyzed Hydration of Carbon Dioxide,” Journal of the American Chemical Society 114, no. 26 (1992): 10498–507. doi:10.1021/ja00052a054
   Web of Science ®Google Scholar
• C. T. Supuran, “Structure and Function of Carbonic Anhydrases,” The Biochemical Journal 473, no. 14 (2016): 2023–32. doi:10.1042/BCJ20160115
   PubMedGoogle Scholar
• Md Imtaiyaz Hassan, Bushra Shajee, Abdul Waheed, Faizan Ahmad, William S. Sly, “Structure, Function and Applications of Carbonic Anhydrase Isozymes,” Bioorganic Medicinal Chemistry 21, no. 6 (2013): 1570–82.
   PubMed Web of Science ®Google Scholar
• A. Scozzafava, M. Passaponti, C. T. Supuran, and İ. Gülçin, “Carbonic Anhydrase Inhibitors: guaiacol and Catechol Derivatives Effectively Inhibit Certain Human Carbonic Anhydrase Isoenzymes (hCA I, II, IX and XII),” Journal of Enzyme Inhibition and Medicinal Chemistry 30, no. 4 (2015): 586–91. doi:10.3109/14756366.2014.956310
   PubMed Web of Science ®Google Scholar
• S. Zamanova, A. M. Shabana, U. K. Mondal, and M. A. Ilies, “Carbonic Anhydrases as Disease Markers,” Expert Opinion on Therapeutic Patents 29, no. 7 (2019): 509–33. doi:10.1080/13543776.2019.1629419
   PubMed Web of Science ®Google Scholar
• C. Potter, and A. Harris, “Diagnostic, Prognostic and Therapeutic Implications of Carbonic Anhydrases in Cancer,” British Journal of Cancer 89, no. 1 (2003): 2–7. doi:10.1038/sj.bjc.6600936
   PubMed Web of Science ®Google Scholar
• A. Ali, A. Ali, M. H. Warsi, M. A. Rahman, M. J. Ahsan, and F. Azam, “An Insight into the Structural Requirements and Pharmacophore Identification of Carbonic Anhydrase Inhibitors to Combat Oxidative Stress at High Altitudes: An in-Silico Approach,” Current Issues in Molecular Biology 44, no. 3 (2022): 1027–45. doi:10.3390/cimb44030068
   PubMed Web of Science ®Google Scholar
• A. Scozzafava, and C. T. Supuran, “Carbonic Anhydrase Inhibitors: Ureido and Thioureido Derivatives of Aromatic Sulfonamides Possessing Increased Affinities for Isozyme I. A Novel Route to 2, 5-Disubstituted-L, 3, 4-Thiadiazoles via Thioureas, and Their Interaction with Isozymes I, II and IV,” Journal of Enzyme Inhibition 13, no. 2 (1998): 103–23. doi:10.3109/14756369809035830
   PubMed Web of Science ®Google Scholar
• I. Feussner, and C. Wasternack, “The Lipoxygenase Pathway,” Annual Review of Plant Biology 53 (2002): 275–97.
   PubMed Web of Science ®Google Scholar
• S. T. Prigge, J. C. Boyington, M. Faig, K. S. Doctor, B. J. Gaffney, and L. M. Amzel, “Structure and Mechanism of Lipoxygenases,” Biochimie 79, no. 11 (1997): 629–36. doi:10.1016/S0300-9084(97)83495-5
   PubMed Web of Science ®Google Scholar
• H. Kuhn, M. Walther, and R. J. Kuban, “Mammalian Arachidonate 15-Lipoxygenases: Structure, Function, and Biological Implications,” Prostaglandins & Other Lipid Mediators 68–69 (2002): 263–90. doi:10.1016/S0090-6980(02)00035-7
   PubMed Web of Science ®Google Scholar
• D. J. Conrad, H. Kuhn, M. Mulkins, E. Highland, and E. Sigal, “Specific Inflammatory Cytokines Regulate the Expression of Human Monocyte 15-Lipoxygenase,” Proceedings of the National Academy of Sciences of the United States of America 89, no. 1 (1992): 217–21. doi:10.1073/pnas.89.1.217
   PubMed Web of Science ®Google Scholar
• G. P. Pidgeon, M. Kandouz, A. Meram, and K. V. Honn, “Mechanisms Controlling Cell Cycle Arrest and Induction of Apoptosis after 12-Lipoxygenase Inhibition in Prostate Cancer Cells,” Cancer Research 62, no. 9 (2002): 2721–7.
   PubMed Web of Science ®Google Scholar
• S. Bhattacharya, G. Mathew, D. G. Jayne, S. Pelengaris, and M. Khan, “15-Lipoxygenase-1 in Colorectal Cancer: A Review,” Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 30, no. 4 (2009): 185–99. doi:10.1159/000236864
   PubMedGoogle Scholar
• L. Zhang, and Z. Xu, “Coumarin-Containing Hybrids and Their Anticancer Activities,” European Journal of Medicinal Chemistry 181 (2019): 111587.
   PubMed Web of Science ®Google Scholar
• A. Saeed, S. A. Ejaz, A. Ul-Hamid, H. R. El-Seedi, and J. Iqbal, “Synthesis of and Molecular Docking Studies of Azomethine-Tethered Sulfonamides as Carbonic Anhydrase II & 15-Lipoxygenase Inhibitors,” Journal of Molecular Structure 1243 (2021): 130821. doi:10.1016/j.molstruc.2021.130821
   Web of Science ®Google Scholar
• F. Mao, M. Wang, J. Wang, and W. R. Xu, “The Role of 15-LOX-1 in Colitis and Colitis-Associated Colorectal Cancer,” Inflammation Research: Official Journal of the European Histamine Research Society 64, no. 9 (2015): 661–9. doi:10.1007/s00011-015-0852-7
   PubMed Web of Science ®Google Scholar
• Y.-M. Zhang, and T.-B. Wei, Synthesis and Biological Activity of N-aroyl-N’-carboxyalkyl Thiourea Derivatives 31, no. 20 (1998): 3099–3105. doi:10.1081/SCC-100105882
   Google Scholar
• S. Y. Abbas, R. A. Al-Harbi, and M. A. S. El-Sharief, “Synthesis and Anticancer Activity of Thiourea Derivatives Bearing a Benzodioxole Moiety with EGFR Inhibitory Activity, Apoptosis Assay and Molecular Docking Study,” European Journal of Medicinal Chemistry 198, no. 1 (2020): 112363–85. doi:10.1016/j.ejmech.2020.112363
   PubMedGoogle Scholar
• İ. Koca, A. Özgür, K. A. Coşkun, and Y. Tutar, “Synthesis and Anticancer Activity of Acyl Thioureas Bearing Pyrazole Moiety,” Bioorganic & Medicinal Chemistry 21, no. 13 (2013): 3859–65. doi:10.1016/j.bmc.2013.04.021
   PubMed Web of Science ®Google Scholar
• S. I. Farooqi, N. Arshad, F. Perveen, P. A. Channar, A. Saeed, and A. Javed, “Aroylthiourea Derivatives of Ciprofloxacin Drug as DNA Binder: Theoretical, Spectroscopic and Electrochemical Studies along with Cytotoxicity Assessment,” Archives of Biochemistry and Biophysics 666 (2019): 83–98. doi:10.1016/j.abb.2019.03.021
   PubMed Web of Science ®Google Scholar
• K. E. Malterud, and K. M. Rydland, “Inhibitors of 15-Lipoxygenase from Orange Peel,” Journal of Agricultural and Food Chemistry 48, no. 11 (2000): 5576–80. doi:10.1021/jf000613v
   PubMed Web of Science ®Google Scholar
• D. R. Appling, Prism 4 GraphPad Software, Inc. 5755 Oberlin Drive,# 110, San Diego, CA 92121. www.graphpad.com. See Web Site for Pricing Information (Washington, DC: ACS Publications, 2003).
   Google Scholar
• C. Kemal, P. Louis-Flamberg, R. Krupinski-Olsen, and A. L. Shorter, “Reductive Inactivation of Soybean Lipoxygenase 1 by Catechols: A Possible Mechanism for Regulation of Lipoxygenase Activity,” Biochemistry 26, no. 22 (1987): 7064–72. doi:10.1021/bi00396a031
   PubMed Web of Science ®Google Scholar
• R. Saito, T. Sato, A. Ikai, and N. Tanaka, “Structure of Bovine Carbonic Anhydrase II at 1.95 Å Resolution,” Acta Crystallographica Section D, Biological Crystallography 60, no. Pt 4 (2004): 792–5. doi:10.1107/S0907444904003166
   PubMedGoogle Scholar
• M. H. Nadri, Y. Salim, N. Basar, A. Yahya, and R. M. Zulkifli, “Antioxidant Activities and Tyrosinase Inhibition Effects of Phaleria Macrocarpa Extracts,” African Journal of Traditional, Complementary, and Alternative Medicines 11, no. 3 (2014): 107–11. doi:10.4314/ajtcam.v11i3.16
   PubMedGoogle Scholar
• M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, Gaussian 09, Revision A.02 (Wallingford CT: Gaussian, Inc., 2016)
   Google Scholar
• R. Dennington, T. A. Keith, and J. M. Millam, GaussView, Version 6.0. 16 (Shawnee Mission, KS: Semichem Inc., 2016).
   Google Scholar
• G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, and A. J. Olson, “AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility,” Journal of Computational Chemistry 30, no. 16 (2009): 2785–91. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• M. Chruszcz, A. Wlodawer, and W. Minor, “Determination of Protein Structures—a Series of Fortunate Events,” Biophysical Journal 95, no. 1 (2008): 1–9.
   PubMed Web of Science ®Google Scholar
• M. Aziz, S. A. Ejaz, N. Tamam, F. Siddique, N. Riaz, F. A. Qais, S. Chtita, and J. Iqbal, “Identification of Potent Inhibitors of NEK7 Protein Using a Comprehensive Computational Approach,” Scientific Reports 12, no. 1 (2022): 1–17. doi:10.1038/s41598-022-10253-5
   PubMed Web of Science ®Google Scholar
• M. Aziz, S. A. Ejaz, H. M. Rehman, A. S. A. Alsubaie, K. H. Mahmoud, F. Siddique, M. S. Al-Buriahi, and Z. A. Alrowaili, “Identification of NEK7 Inhibitors: Structure Based Virtual Screening, Molecular Docking, Density Functional Theory Calculations and Molecular Dynamics Simulations,” Journal of Biomolecular Structure and Dynamics 7 (2022): 1–15. doi:10.1080/07391102.2022.2113563
   Google Scholar
• S. Yuan, H. S. Chan, and Z. Hu, “Using PyMOL as a Platform for Computational Drug Design,” Wiley Interdisciplinary Reviews: Computational Molecular Science 7, no. 2 (2017): e1298.
   Web of Science ®Google Scholar
• R. A. Laskowski, and M. B. Swindells, LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery (Washington, DC: ACS Publications, 2011).
   Google Scholar
• J. C. Phillips, D. J. Hardy, J. D. C. Maia, J. E. Stone, J. V. Ribeiro, R. C. Bernardi, R. Buch, G. Fiorin, J. Hénin, W. Jiang, et al, “Scalable Molecular Dynamics on CPU and GPU Architectures with NAMD,” The Journal of Chemical Physics 153, no. 4 (2020): 044130. doi:10.1063/5.0014475
   PubMed Web of Science ®Google Scholar
• W. Humphrey, A. Dalke, and K. Schulten, “VMD: Visual Molecular Dynamics,” Journal of Molecular Graphics 14, no. 1 (1996): 33–8. doi:10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• S. Kim, J. Lee, S. Jo, C. L. Brooks 3rd, H. S. Lee, W. Im, CHARMM‐GUI Ligand Reader and Modeler for CHARMM Force Field Generation of Small Molecules (Hoboken, NJ: Wiley Online Library, 2017).
   Google Scholar
• S. Rasheed, M. Aziz, A. Saeed, S. A. Ejaz, P. A. Channar, S. Zargar, Q. Abbas, H. Alanazi, M. Hussain, M. Alharbi, et al, “Analysis of 1-Aroyl-3-[3-Chloro-2-Methylphenyl] Thiourea Hybrids as Potent Urease Inhibitors: Synthesis, Biochemical Evaluation and Computational Approach,” International Journal of Molecular Sciences 23, no. 19 (2022): 11646. doi:10.3390/ijms231911646
   PubMed Web of Science ®Google Scholar
• P. L. Barclay, and D. Z. Zhang, “Periodic Boundary Conditions for Arbitrary Deformations in Molecular Dynamics Simulations,” Journal of Computational Physics 435 (2021): 110238. doi:10.1016/j.jcp.2021.110238
   Web of Science ®Google Scholar
• G. Xiong, Z. Wu, J. Yi, L. Fu, Z. Yang, C. Hsieh, M. Yin, X. Zeng, C. Wu, A. Lu, et al., “ADMETlab 2.0: An Integrated Online Platform for Accurate and Comprehensive Predictions of ADMET Properties,” Nucleic Acids Research 49, no. W1 (2021): W5–W14. doi:10.1093/nar/gkab255
   PubMed Web of Science ®Google Scholar